Shorter blood thinner therapy after heart stents
Part of Heart & circulation clinical trials.
This study is comparing two durations of antiplatelet therapy (blood thinners) after getting a heart stent, using ultrasound guidance to tailor the treatment. The goal is to find a shorter, safer medication plan that still prevents blood clots and heart attacks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You are having or have had a stent placed in a blocked heart artery (PCI with drug-eluting stents).
- The reason for the stent must be unstable angina (chest pain at rest or getting worse), a heart attack, or stable coronary disease that needs treatment.
- You must be able to give informed consent.
- You must not have had a stroke or permanent brain injury in the last 3 months.
- You must not have severe kidney disease (dialysis or very low kidney function).
- You must not be taking a daily blood thinner for another condition, and you must not be allergic to aspirin or antiplatelet drugs.
- You must not have had prior bypass surgery or have planned surgery in the next year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a shorter course of blood-thinning medication after heart stent placement is safer and just as effective for older adults. It aims to reduce bleeding risks while still preventing heart attacks and strokes.
This trial compares two ways of using anti-platelet (blood-thinner) medicines after a specific kind of heart attack (STEMI) treated with a stent. It aims to see if switching sooner to one medicine (instead of two for longer) works just as well and may reduce risks.
This trial compares 12 months versus 24 months of dual antiplatelet therapy (two blood thinners) after a stent placement in people with high lipoprotein(a) levels. It aims to see if longer treatment reduces heart risks without increasing bleeding.
This study compares two ways to manage blood thinners after a stent. It tests whether switching from stronger drugs (prasugrel or ticagrelor) to clopidogrel is safe and effective for long-term heart protection.
This trial looks at whether using heart imaging (OCT or angiogram) to guide how long you take two blood thinners after a heart attack (STEMI) can be safe and effective. If you qualify, your doctor may be able to reduce your blood thinner use sooner, which could lower bleeding risk while still protecting your heart.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
Hear when a new Coronary Arterial Disease (CAD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.